Categories AlphaGraphs, Earnings, Health Care
Infographic: Key highlights from Biogen (BIIB) Q2 2022 earnings results
Biogen Inc. (NASDAQ: BIIB) reported second quarter 2022 earnings results today.
Total revenue decreased 7% year-over-year to $2.58 billion.
Net income attributable to Biogen Inc. was $1 billion, or $7.24 per share, compared to $448.5 million, or $2.99 per share, last year. Adjusted EPS was $5.25.
Biogen raised its revenue and adjusted EPS guidance for the full year of 2022 based on better-than-expected topline performance and continued cost management. For FY2022, revenue is now expected to be $9.9-10.1 billion and adjusted EPS is now expected to be $15.25-16.75 compared to the previous ranges of $9.7-10 billion for revenue and $14.25-16.00 for adjusted EPS.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Docusign (DOCU) Earnings: 4Q25 Key Numbers
Docusign, Inc. (NASDAQ: DOCU) reported total revenue of $776.3 million for the fourth quarter of 2025, up 9% year-over-year. Net income was $83.5 million, or $0.39 per share, compared to
DG Q4 Call Highlights: Consumer Shifts, Inventory Wins, and Rural Delivery Boom!
Dollar General Corp., a retailer that operates discount stores, in its Q4 earnings call discussed Dollar General's financial strategy to reach 6-7% operating margins by 2028 through shrink reduction, inventory
ULTA Earnings: Highlights of Ulta Beauty’s Q4 2024 results
Ulta Beauty, Inc. (NASDAQ: ULTA), a leading retailer of cosmetics and personal care products, on Thursday reported a decrease in net sales for the fourth quarter of 2024. Fourth-quarter net
